@h_hellmut profile picture
Thomas H Schindler @h_hellmut
Joined January 2015
  • Tweets 36
  • Following 49
  • Followers 63
1 Photos and videos
FDA Approval of 18F-Flurpiridaz Is for PET: Stepping into a New Area of Myocardial Perfusion Imaging? pubmed.ncbi.nlm.nih.gov/4024…

FDA Approval of 18F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging? -...

FDA Approval of 18F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging?

pubmed.ncbi.nlm.nih.gov
1
34
Thomas H Schindler retweeted
Oscar Cingolani, MD@cingolani_oscar
22 May 2024
Terrific @hopkinsheart Grand Rounds today by Dr. Thomas Schindler @h_hellmut on PET/CT assessment of coronary morphology and flow. @CiccaroneCenter
1
3
12
978
Needs to be faster if you want to lose some calories Stephan ! :)
Stephan Achenbach@Steph_Achenbach
11 Aug 2023
On my way to on-call STEMI. Lucky to be living in a small town (w/ large hospital) where I can bike to the cath lab on a summer night (or winter, when the time comes) and still arrive before the patient #cardiotwitter @escardio @HolgerNef @JEscaned @ESC_President @Drroxmehran
0:18
99
Thomas H Schindler retweeted
Stephan Achenbach@Steph_Achenbach
11 Aug 2023
On my way to on-call STEMI. Lucky to be living in a small town (w/ large hospital) where I can bike to the cath lab on a summer night (or winter, when the time comes) and still arrive before the patient #cardiotwitter @escardio @HolgerNef @JEscaned @ESC_President @Drroxmehran
0:18
27
26
489
63,931
Angiography-Derived FFR as Novel Parameter in Assessing Flow-Limiting CAD? Commentary pubmed.ncbi.nlm.nih.gov/3711… on Westra et al. doi.org/10.1016/j.jcmg.2023.… Comparable diagnostic accuracy of QFR and invasively measured FFR but low concordance with PET determined MFR.

Angiography-Derived FFR as Novel Parameter in Assessing Flow-Limiting CAD? - PubMed

Angiography-Derived FFR as Novel Parameter in Assessing Flow-Limiting CAD?

pubmed.ncbi.nlm.nih.gov
1
61
Published in IJC Heart & Vasculature. DOI: lnkd.in/gkCvdHnV In this analysis in a symptomatic cardio-metabolic risk population, 54% had evidence of coronary microvascular dysfunction (CMD) as determined with PET. Thereof, 65% had classical CMD and 35% had endogen CMD.

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
2
55
Thomas H Schindler retweeted
Less-Is-More Cardiologist@DavidLBrownMD
22 Nov 2022
Good morning California!
9
1
64
Thomas H Schindler retweeted
theodoreabraham@tabrahammd
21 Jul 2022
Hellow Tweetverse! Good morning to all! @ucsf_echo @UCSF @UCSFMedicine @UCSFCardiology @ASE360 @hcmsociety @ethanweiss @RWASECEO @SLittleMD @ray_stainback @mswami001 @ErinMichos @iamritu @MasriAhmadMD @scauduro
7
4
30
Thomas H Schindler retweeted
WashU Medicine Mallinckrodt Institute of Radiology@WashUMedMIR
29 Mar 2022
This #WomensHistoryMonth, we're shining a spotlight on #RadWomen leaders at MIR. Farrokh Dehdashti, MD, is the Drs. Barry A. & Marilyn J. Siegel Professor of Radiology, senior vice chair and division director of nuclear medicine.
2
6
36
18F-FDG Positron Emission Tomography in Myocardial Viability Assessment: A Practical and Time Efficient Protocol jnm.snmjournals.org/content/…
Using a practical and time efficient protocol for i.v. glucose loading and insulin administration prior to 18F-FDG injection reduces the metabolic preparation period (MPP) by 61% as compared to oral glucose challenge that affords good-to-excellent image quality in 95% of ischemic cardiomyopathy patients. Overall, the 18F-FDG PET study for viability assessment in ischemic CMP can be performed in about 120 to 140 min. This practical and time efficient protocol should revamp the use of 18F-FDG PET in cardiac viability assessment in clinical practice

ALT Using a practical and time efficient protocol for i.v. glucose loading and insulin administration prior to 18F-FDG injection reduces the metabolic preparation period (MPP) by 61% as compared to oral glucose challenge that affords good-to-excellent image quality in 95% of ischemic cardiomyopathy patients. Overall, the 18F-FDG PET study for viability assessment in ischemic CMP can be performed in about 120 to 140 min. This practical and time efficient protocol should revamp the use of 18F-FDG PET in cardiac viability assessment in clinical practice
2
Thomas H Schindler retweeted
Leslee Shaw@lesleejshaw
20 Jul 2021
Ha, we will see!
Yael L. Maxwell@TCTMD_Yael
20 Jul 2021
A long-awaited US chest pain guidelines update is now expected for Aug/Sept, but whether the new advice will match the approach taken in Europe/UK remains unclear tctmd.com/news/new-guideline… @ToddVillinesMD @JWeirMcCall @Steph_Achenbach @RonBlankstein @CardiacCTGuy #SCCT2021
2
2
12
Thomas H Schindler retweeted
CardioTomLuscher@TomLuscher
3 Jul 2021
A Farewell in joy: The EHJ IF 2019-2020 is 29.983! Thank you to the team that made this possible - more than triple compared to 2009! I hardly can believe it. Thank you to authors who provided their best work and to the readers who cited it. All the best to Filippo Crea for 2021
10
24
143
Thomas H Schindler retweeted
Pamela Woodard, MD@PamelaWoodardp
3 Jun 2021
On vacation - Just took a walk around Great Pond - doesn’t get better than this
2
1
30
Thomas H Schindler retweeted
CardioTomLuscher@TomLuscher
12 Dec 2018
What do the new hypertension guidelines mean for clinical practice? Don't miss the lecture of Mel Lobo at the Cardiology Update London at the Royal Society of Meicine this Monday. You hear about drugs and devices and the right traget BP - it is important for your practice
2
2
7
Hi @kell_pierre.
8
Load more